Physician profile
Patrick M Bennett
NPI 1891713418
$6,108.54
in general payments reported to CMS, 2019-2025
44 companies · $1,124 in 2025
The $1,124 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $258 · 2021: $433 · 2022: $735 · 2023: $1,532 · 2024: $1,581 · 2025: $1,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,237.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $955.64 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $687.73 | 2019-2025 | Botox, Lupron Depot |
| Boston Scientific Corporation | $413.64 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $403.65 | 2019-2024 | Myrbetriq |
| Rochester Medical Corporation | $334.44 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $257.39 | 2019-2025 | Bard Urinary Drainage Bag |
| Ferring Pharmaceuticals INC. | $228.87 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $213.54 | 2021-2025 | Jelmyto |
| Telix Pharmaceuticals | $199.21 | 2024-2025 | Illuccix |
| Blue Earth Diagnostics | $195.04 | 2021-2023 | |
| Axonics, INC. | $185.23 | 2021-2024 | Axonics |
| Janssen Biotech, INC. | $176.43 | 2019-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $138.44 | 2025 | |
| Pfizer INC. | $137.85 | 2023-2025 | |
| Laborie Medical Technologies Corp. | $121.38 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $115.37 | 2021-2024 | |
| Allergan, INC. | $108.61 | 2019-2022 | |
| Edap Technomed INC | $100.00 | 2023 | |
| Myriad Genetic Laboratories, INC. | $97.31 | 2022-2024 | Prolaris |
| Procept Biorobotics Corporation | $79.51 | 2024-2025 | Aquabeam System |
| Olympus America INC. | $76.58 | 2022-2025 | Itind System |
| Becton, Dickinson and Company | $75.76 | 2024 | Bard Urinary Drainage Bag |
| Profound Medical Corp. | $70.90 | 2025 | Tulsa-Pro |
| Dendreon Pharmaceuticals LLC | $60.39 | 2019-2024 | Provenge |
| Tolmar, INC. | $58.77 | 2023 | |
| Convatec INC. | $55.75 | 2024 | |
| Ethicon US, LLC | $47.65 | 2021-2025 | Stratafix, Dermabond Prineo, Vistaseal |
| Teleflex LLC | $42.43 | 2022-2023 | Urolift |
| Neotract INC. | $38.26 | 2019 | |
| Davol INC. | $37.83 | 2025 | Arista |
| Coloplast Corp | $37.72 | 2021-2024 | |
| Antares Pharma, INC. | $37.51 | 2023 | Tlando, Xyosted, Nocdurna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.86 | 2019-2021 | |
| Sagent Pharmaceuticals | $35.39 | 2022 | |
| Angiodynamics, INC. | $33.84 | 2021-2023 | Nanoknife |
| Immunitybio, INC. | $31.44 | 2024 | |
| Smith+Nephew, INC. | $31.15 | 2025 | Stravix |
| Palette Life Sciences, INC. | $28.24 | 2022 | |
| Amgen INC. | $24.88 | 2020 | |
| Accord Healthcare, INC. | $23.81 | 2024 | |
| Myovant Sciences INC. | $22.68 | 2022 | |
| Abbott Laboratories | $20.68 | 2021 | |
| Halozyme INC | $17.41 | 2023 | |
| Sanofi Pasteur INC. | $14.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.